The Taiwan Excellence Smart Medical and Biotesting Webinar was held last Thursday, Oct. 14th.
The webinar featured four medtech brands from Taiwan, all of whom are the winners of this year’s Taiwan Excellence Awards, presenting their latest medical and health innovations, including TANbead’s Automated Nucleic Acid Extractor, Miicraft’s Optical 3D Printer, Aeon’s Acid PRP and A-BMC treatment, and EZYPRO®, an Arrhythmia Diagnostic Solution from Sigknow, demonstrate Taiwan’s strengths in biotesting and customized treatment, also highlighting the upcoming trend of diversification and specialization in healthcare industry.
“Under the threat of pandemic, we are seeing the new emerging business model of biomedical industries, medical services are moving from centralized to personalized to look after the individual needs, and smart medical care is believed to be the next wave that could change the world,” remarked Dr. Chii-Wann Lin, vice president and Director of Biomedical Technology and Device Research Laboratories in Taiwan Industrial Technology Research Institute.
With the help from the solid foundation of the country’s ICT industry, Taiwan’s healthcare leaders are now eager to expand its presence in post-pandemic competition by combining biotesting solutions, preventive medicine, telemediation and customized health equipment.
Overall, the webinar proceeded with constructive and informative manner, with lively interaction between audience around the world and the speakers.
COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by The Standard. Comments are views by thestandard.ph readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of thestandard.ph. While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with The Standard editorial standards, The Standard may not be held liable for any false information posted by readers in this comments section.